Tracker

CDSCO approvals

CDSCO's list of new drug and clinical trial approvals holds 245 permission letters dated 2024, from January 1, 2024 to December 30, 2024. GCT is the most common kind of permission, with 116. Each row gives the company, product, kind of permission, date and a link to the letter, and CDSCO's file number where its text gives it.

From CDSCO's CT Approvals list, read . Each product links to CDSCO's PDF of its letter. The date is the one CDSCO gives on its list; the file number is printed in the letter. Not stated: file number on 6 rows. The file number is not read from 48 scanned letters: we read a letter's text, not its image. CDSCO's link did not open for 1 letter, so its file number is not shown.

The kinds of permission are CDSCO's own. FDC is fixed-dose combination (CDSCO's guidance for its Subject Expert Committees, page 13); GCT is global clinical trial (CDSCO's FAQs on the New Drugs and Clinical Trials Rules, page 8); SND is Subsequent New Drugs (CDSCO's Citizen's Charter, page 2); rDNA is recombinant Deoxyribonucleic Acid (CDSCO's FAQs on the New Drugs and Clinical Trials Rules, page 3, which that page writes r-DNA).

December 2024

November 2024

October 2024

September 2024

August 2024

July 2024

June 2024

May 2024

April 2024

March 2024

February 2024

January 2024